4//SEC Filing
Goldan Keith A. 4
Accession 0000950170-25-096948
CIK 0001395937other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:30 PM ET
Size
4.6 KB
Accession
0000950170-25-096948
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-16$9.29/sh−1,296$12,033→ 92,450 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:30 PM ET
- Size
- 4.6 KB